Efficacy of alendronate 70mg once-weekly in postmenopausal Chinese women with osteopororis

被引：0
|
作者：
Ho, AYY [1 ]
Kung, AWC [1 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
BONE | 2003年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [1] The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis
    Yuxiang Yan
    Wei Wang
    Hanmin Zhu
    Mei Li
    Jianli Liu
    Bangyao Luo
    Haibao Xie
    Guangjian Zhang
    Fuobao Li
    Journal of Bone and Mineral Metabolism, 2009, 27 : 471 - 478
  • [2] The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis
    Yan, Yuxiang
    Wang, Wei
    Zhu, Hanmin
    Li, Mei
    Liu, Jianli
    Luo, Bangyao
    Xie, Haibao
    Zhang, Guangjian
    Li, Fuobao
    JOURNAL OF BONE AND MINERAL METABOLISM, 2009, 27 (04) : 471 - 478
  • [3] Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis
    Sebba, AI
    Bonnick, SL
    Kagan, R
    Thompson, DE
    Skalky, CS
    Chen, EL
    de Papp, AE
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (12) : 2031 - 2041
  • [4] The effects of once-weekly alendronate 70 mg on bone metabolism of postmenopausal women in Korea.
    Kim, H
    Shon, H
    Choi, J
    Lee, H
    Kim, E
    Park, I
    Park, I
    Kim, B
    Lee, I
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S394 - S394
  • [5] Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: A randomized double-blind study
    Rosen, CJ
    Hochberg, MC
    Bonnick, SL
    McClung, M
    Miller, P
    Broy, S
    Kagan, R
    Chen, E
    Petruschke, RA
    Thompson, DE
    de Papp, AE
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (01) : 141 - 151
  • [6] Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis
    Luckey, M
    Kagan, R
    Greenspan, S
    Bone, H
    Kiel, RDP
    Simon, J
    Sackarowitz, J
    Palmisano, J
    Chen, E
    Petruschke, RA
    de Papp, AE
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (04): : 405 - 415
  • [7] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, ME
    Wang, L
    Thompson, D
    Yates, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S43 - S44
  • [8] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Melton, M
    Lewiecki, EM
    Rosen, R
    Bockman, RS
    Dinh, AC
    Smith, ME
    Wang, L
    Keene, W
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S36 - S36
  • [9] Safety of once-weekly alendronate 70 mg in periodontal disease
    Van Dyke, T
    Ryder, M
    Cordero, R
    Gallagher, A
    Griffiths, G
    Offenbacher, S
    Cizza, G
    Kimberlin, M
    Lombardi, A
    Meng, L
    Shih, W
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 26 - 26
  • [10] In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70mg) and in vivo implications
    Dansereau, Richard J.
    Crail, Debbie J.
    Perkins, Alan C.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (04) : 1137 - 1145
12345